QuidelOrtho Corporation
QDEL · NASDAQ
9/28/2025 | 6/29/2025 | 3/30/2025 | 12/29/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.00 | 0.51 | -0.01 |
| FCF Yield | -2.94% | -2.07% | 3.21% | 0.56% |
| EV / EBITDA | -3.10 | -62.73 | 34.22 | 306.07 |
| Quality | ||||
| ROIC | -13.46% | -0.01% | 0.81% | -1.89% |
| Gross Margin | 93.18% | 37.12% | 49.55% | 46.07% |
| Cash Conversion Ratio | 0.06 | 0.18 | -5.17 | -0.36 |
| Growth | ||||
| Revenue 3-Year CAGR | -4.54% | -4.63% | -3.85% | -5.20% |
| Free Cash Flow Growth | -43.18% | -153.24% | 358.79% | -76.89% |
| Safety | ||||
| Net Debt / EBITDA | -0.31 | -36.08 | 17.83 | 142.71 |
| Interest Coverage | -15.29 | -0.01 | 0.77 | -2.25 |
| Efficiency | ||||
| Inventory Turnover | 0.08 | 0.67 | 0.09 | 0.72 |
| Cash Conversion Cycle | 804.61 | 141.81 | 679.83 | 125.22 |